A Review on the Management of Acute Gastroenteritis in Children
-
Upload
anonymous-1equtb -
Category
Documents
-
view
214 -
download
0
Transcript of A Review on the Management of Acute Gastroenteritis in Children
-
7/27/2019 A Review on the Management of Acute Gastroenteritis in Children
1/9
Hong Kong Journal of Emergency Medicine
A review on the management of acute gastroenteritis in children
KC Shek , P Ng , CY Hung , KK Lam , CL Lau , WM Ching ,
CW Kam
Acute gastroenteritis represents a frequent cause of morbidity among children in Hong Kong. Despite the
large number of potential etiologic agents, principles of management of gastroenteritis are uniform and
aim to prevent the two major complications dehydration and malnutrition. A review of the literature was
performed. Selected articles were appraised, graded, and synthesised qualitatively. Statements on
recommendations were generated. Current evidence emphasises the use of oral rehydration and the early
reintroduction of age-appropriate foods. Apart from these two, important aspects of management reviewed
included laboratory investigations, role of anti-diarrhoeal agents, and use of anti-microbial agents. Criteria
for admission of high-risk children are also addressed. (Hong Kong j.emerg.med. 2004;11:152-160)
Keywords: Anti-diarrhoeals, anti-infective agents, diarrhoea, fluid therapy, oral administration
Correspondence to:Shek Kam Chuen, MBBS, FRCSEd, FHKAM(Emergency Medicine)Tuen Mun Hospital, Accident and Emergency Department, TsingChung Koon Road, Tuen Mun, N.T., Hong KongEmail: [email protected]
Paulin Ng,MBChB, FRCSEd, FHKAM(Emergency Medicine)Hung Chung Yung, MBBS, FRCSEd, FH KAM(Emergency Medicine)Lam Ka Keung, MBBS, MRCSEdLau Chu Leung, MBBS, MRCSEdChing Wai Ming, MBChB, MRCSEdKam Chak Wah, MRCP, FRCSEd, FHKAM(Emergency Medicine & Surgery)
Background
Acute gastroenteritis is characterised by rapid onset
of diarrhoea with or without vomiting, nausea, fever,and abdominal pain.1 It is a common paediatric illness
often treated in emergency departments and
outpatient clinics. In the United States, most children
younger than five years old have gastroenteritis two
to three times a year; while children attending daycare have approximately five illnesses per year.2 In
Hong Kong, acute gastroenteritis contributed one-
sixth of the paediatric admission in a teaching hospital
and caused 10 out of 2,737 post-neonatal deaths
between 1980-1992.3
Acute gastroenteritis is a clinical syndrome produced
by a variety of viral, bacterial, and parasitic
enteropathogens. In developed countries, viral
enteropathogens cause 30-40% of all infectious
diarrhoeal diseases. Rotaviruses are the most commonviral enteropathogens in children and they are
-
7/27/2019 A Review on the Management of Acute Gastroenteritis in Children
2/9
Shek et al./Acute gastroenteritis in children 153
responsible for 40% of dehydrating diarrhoeal cases.2,4
Enteric adenoviruses are the second most common
cause of viral diarrhoea, isolated from a median of3% (range 0 to 6%) of the cases.4 Limited data are
available in Hong Kong. In an Acute Diarrhoeal
Diseases Surveillance (pilot program) conducted by
the Department of Health in 2001, stool specimens
were collected from selected patients (both adults and
children) attending 64 general outpatient clinics with
acute diarrhoeal diseases. Vi bri o parahaemolyticus,
Salmonella and Campylobacter were found 28, 27 and
17 out of 565 specimens respectively. Norwalk-like
viruses and Rotavirus were found in 52 and 7 out of
600 specimens respectively.
There are great variations in management of acute
gastroenteritis in Hong Kong. In one study looking
at the management practice by primary care physicians
and parents' perception of appropriate treatment of
acute diarrhoea in Hong Kong, mi smanagement
predominated both among the professionals and
laypeople. Oral rehydration solut ion (ORS) was only
recommended by 14% of their primary care doctors.
Other advices included giving more water (37%), lessmilk (7%) and soya-based mi lk (21%). Caregivers' top
priorities for the treatment of diarrhoeal illness in
children were fever control (41%) followed by
replacing fluid loss (30%), stopping diarrhoea (26%)
and stopping vomiting (4%). Only half of the
caregivers considered it important to continue giving
solid foods, and soft cereal foods (congee and bread)
were favoured. There was also a strong belief that drugs
should be given.3
Objectives
This article is intended to provide an evidence-based
recommendation for the management of children who
present to hospital with diarrhoea. Clinical assessment,
investigations (biochemistry and stool culture in
particular), admission, and treatment are addressed.
The review aims to aid doctors in recognising children
who need admission for observation and treatment
and those who may safely go home.
Method: search strategy and evaluation ofevidence
The search was performed using the MED LI NE,
EMBASE, ACP Journal club, DARE, CCTR, CDSR,
and Cinahl databases, and covered the years January
1966-February 2003. Relevant articles were also
identified from the references cited in publications
identified from these databases. The search was limited
to studies of human subjects published in English.
Subject headings employed were: "gastroenteritis",
"diarrhoea", "rehydration solutions" and
"dehydration". Text word searches were also done
using the terms "infectious diarrhoea" and "oral
rehydration solutions". For each topic the terms
"review", "meta-analysis", "clinical trials" and
"randomised controlled trial" were applied. The
Cochrane Library database of systematic reviews was
searched under the subject headings. Evidence from
the medical literature and the strength of the
recommendations given were then categorised
according to the scheme quoted in EVIDENCE,
which was published by the Hospital Authority of
Hong Kong (Table 1).5
Fluid replacement
Management of gastroenteri tis start s with a bri ef,
focused history that should include information on
the nature of symptoms (mainly diarrhoea and
vomiting), their frequency and duration, the amount
and type of fluids ingested during the last 24 hours,
and urine output. This should be followed by an
assessment of the hydration status of the patient, based
primarily on physical signs, as shown in Table 2. 4
However, the severity of dehydration is most
accurately assessed i n terms of weight loss as a
percentage of premorbid body weight.6 Physical
examination is useful in distinguishing gastroenteri tis
from other acute surgical abdominal conditions. The
introduction of oral replacement therapy (ORT) has
revolutionised the management of dehydration in
acute gastroenteritis. It is a simple and inexpensive
treatment. The basis of ORT is that an active co-
-
7/27/2019 A Review on the Management of Acute Gastroenteritis in Children
3/9
Hong Kong j. emerg. med.Vol. 11(3)Jul 2004154
Table 1. Classifi cation scheme5
Category of evidence:
Ia Evidence from meta-analysis of randomised controlled trials
Ib Evidence from at least one randomised controlled trial
I Ia Evidence from at least one controlled study without randomisation
IIb Evidence from at least one other type of quasi-experimental study
III Evidence from non-experimental descriptive studies, such as comparative studies, correlation studies, and case-control studies
IV Evidence from expert commit tee reports or opinions or clinical experience of respected authorit ies, or both
Strength of recommendation:
A Directly based on category I evidence
B Directly based on category II evidence or extrapolated recommendation from category I evidence
C Directly based on category III evidence or extrapolated recommendation from category I or I I evidence
D Di rectly based on category IV evidence or extrapolated recommendation from category I , I I or I I I evidence
Table 2. Assessment of dehydration4,7
Variable Mild (3% -5% ) Moderate (6% -9% ) Severe (10% )
Blood pressure Normal Normal Normal to reduced
Quality of pulse Normal Normal or slightly decreased Moderately decreased
Heart rate Normal Increased Increased
Skin turgor Normal Decreased Decreased
Fontanelle Normal Sunken Sunken
Mucous membranes Slightly dry Dry DryEyes Normal Sunken orbits Deeply sunken orbits
Extremities Warm, normal capillary refill Delayed capillary refill Cool, mottled
Mental status Normal Normal to listless Normal to lethargic or comatose
Urine output Slightly decreased
-
7/27/2019 A Review on the Management of Acute Gastroenteritis in Children
4/9
Shek et al./Acute gastroenteritis in children 155
generally recommended rehydration regime is as
follows: -6,7
(a) "Mild" dehydration (3-5%):30-50 ml/kg as ORT over 3-4 hours
(b) "Moderate" dehydration (5-10%):
50-100 ml/kg as ORT over 3-4 hours
(c) "Severe" dehydration (>10%):
100-150 ml/kg as ORT over 3-4 hours
In case of severe dehydration with signs of shock,
20 ml/kg boluses of normal saline should be given
int ravenously [ IV, D].6,10 Sandhu et al noted that
the indications for intravenous therapy included
(1) shock, (2) >10% dehydration, or (3) failure of oral
replacement therapy [IV, D].10 We should reassess the
patient's hydration status and tolerance of fluid
regularly. Continue to supplement with ORS 10 ml/
kg for each watery stool or vomitus until the child
recovers.6,7,10 ORS with sodium concentrations as high
as 90 mmol/L or as low as 30 mmol/L appear to be
equally effective and safe [Ia, A].8 An ORS containing
sodium 60 mmol/L, glucose 90 mmol/L, potassium
20 mmol/L, and citrate 10 mmol/L with a low
osmolality of 240 mmol/L is safe and effective for theprevention and treatment of dehydration in European
children with acute gastroenteritis [Ib, A].6 A range
of ORS products are currently available in Hong
Kong, and these vary in their sodium and glucose
concentrations (Table 3).12
Although glucose-electrolyte ORS is extremely
effective in replacing fluid and electrolyte losses, it
has no effect on stool volume. Comparing with
standard ORS, one systematic review noted that rice-
based ORS for children with cholera had resulted in
significant reduction of 24-hour stool volume [Ib, A].13
Although rice-based ORS is well tolerated in infantsyounger than 6 months of age, more evidence is
required to justify its replacement of the glucose-based
hypotonic oral rehydration solutions.14
There is no systematic review or RCTs on "clear
fl uids" (water, carbonated dr inks, and t ranslucent
fruit juices) versus ORS for treatment of mild to
moderate dehydration caused by acute gastroenteritis.
Fruit juices and carbonated drinks are of low
electrolyte concentration but hypertonic owing to the
high sugar content. These solutions may exacerbate
diarrhoea [IV, D].7
Nutritional management
Conventional practice to treat acute gastroenteritis was
to delay feeding for 24 hours. Some might also
recommend the use of diluted milk formula or lactose-
free formula routinely. These practices have become
obsolete. Studies have shown that early refeeding ofage-appropriate food has the advantages of stimulating
mucosal growth and reducing the abnormal increase
in intestinal permeability in acute gastroenteritis [Ib,
A].12,15 Besides, early resumption of age-appropriate
food helps to meet the nutritional needs of the ill child.
In a recent multicentre European study, 230 weaned
children under three years of age with acute
gastroenteritis were randomly assigned to "early
refeeding" or "late refeeding". These children were not
Table 3. Composition of glucose-electrolyte solution12 (Adapted from: Yeung WKY. Acute gastroenteritis in infants and children.
Hong Kong Pract 1999;21:471-6.)
Solution Carbohydrate (mmol/L) Sodium (mmol/L) Potassium (mmol/L) Base (mmol/L) Osmolarity (mOsm/L)
Pedialyte 140 45 20 30 250
GES45 160 45 25 25 300
Infalyte 70 50 25 30 200
Rehydrate 140 75 20 30 310
WHO 111 90 20 30 310
Glucolyte 100 56 20 NA 240
-
7/27/2019 A Review on the Management of Acute Gastroenteritis in Children
5/9
Hong Kong j. emerg. med.Vol. 11(3)Jul 2004156
generally malnourished before the onset of their
illness. Oral rehydration was carried out over four
hours. The "early refeeding" group then received anormal diet without further delay. The "late refeeding"
group received maintenance ORS for a further 20
hours, and then restarted a normal diet. Both groups
were offered ORS 10 ml/kg after each watery stool.
There was no difference between the two groups in
the incidence of vomiting or watery stools on days
1 to 5, and weight gain was similar in both groups on
days 5 and 14.16 Breastfeeding should continue
through rehydration and maintenance phases of
treatment [IIb, B].6,10,17 Breastfeeding not only reduces
exposure to enteropathogens but also provides a variety
of humoral and cellular factors protective against
intestinal infection. Formula feeds should be restarted
after completion of rehydration [Ib, A].6
Transient lactase deficiency is common, particularly
after Rotavirus gastroenteri tis. However, persistent
lactose intolerance causing post-gastroenteritis
diarrhoea is a rather uncommon clinical problem.18 A
meta-analysis on the use of lactose-containing
formulas in children with diarrhoea noted that 80%or more could tolerate full-strength milk safely [Ia,
A]. However, children with severe diarrhoea might
have an increased rate of complications, though, and
for them lactose-reduced formulas should be
considered.18 If there is persistent diarrhoea after
reintroduction of feeds, evidence for lactose
intolerance should be sought. I f the stool pH is acidic
and contains more than 0.5% of reducing substances,
a lactose-free formula should be considered [III, C].6
Fatty foods or foods high in simple sugars (including
tea, juices, and soft drinks) should be avoided.4
Investigation modalities
Despite the large number of potential etiologic agents,
principles of management of acute gastroenteritis are
uniform and aim to prevent the two major
complications dehydration and malnutrition.
Microbiological investigation is not necessary in every
case,
4,6
but indicated in selected patients who require
admission to hospital, who have bloody or mucoid
diarrhoea suggesting colitis, who are immuno-
compromised, and in cases where there are diagnosticuncertainties [IV, D].6 When comprehensive
microbiologic methods are used, etiologic agents can
be identified in only about 50% of diarrhoea cases in
community-based studies and 70% in health-facility
cases.19 Besides, the finding of an enteropathogen in
the stool of a patient with gastroenteritis does not
establish a causal relationship. It has been estimated
that the culture-positive rate for Salmonella and
Shigella in unselected stool specimens from patients
with diarrhoea is 1.5-2.4%. Using the presence of
faecal leucocytes as a selection criterion for performing
stool cultures has been shown to increase the rate from
2% to 76%.20 Antigen testing for Rotavirus is a
valuable and sensitive test, which should be performed
in all young children under the age of three years who
are hospitalised with severe diarrhoea.21
Gross examination of the stool may help distinguish
the infectious causes of diarrhoea. Watery diarrhoea
without blood or mucus is indicative of a viral or an
enterotoxin-mediated bacterial infection. D iarrhoeacontaining blood, mucus, or both is indicative of a
cytotoxin-mediated or an enteroinvasive inflammatory
process.20 The presence of gross or occult blood in the
stool should raise suspicion of such pathogens as
Shigella species, Campylobacter species and
haemorrhagic E. coli strains.22
Medications
According to a few systematic reviews and RCTs, anti-
diarrhoeal and anti-moti li ty agents are not clinically
beneficial in the management of acute childhood
gastroenteritis, and their side effect profile is
unacceptable. Infants and children with acute
gastroenteritis should not be treated with anti-
diarrhoeal agents [Ib, A] .6,7 Bacterial gastroenteritis is
usually self-limited in the otherwise healthy child.
Clinical recovery is frequently achieved within a few
days and excretion of the causative organisms
continues for a relatively short duration, usually not
-
7/27/2019 A Review on the Management of Acute Gastroenteritis in Children
6/9
Shek et al./Acute gastroenteritis in children 157
exceeding a few weeks. Most bacterial gastroenteritis
do not require or benefit from antibiotic treatment.6,14
Loperamide (Imodium)
There is no meta-analysis study on the use of
loperamide in acute gastroenteritis. Four RCTs have
demonstrated the beneficial effect of loperamide.23-26
Three RCTs comparing loperamide at doses of 0.4
mg/kg/day and 0.8 mg/kg/day (higher than the
recommended dose) with standard ORT versus
placebo with standard ORT had statistically significant
favourable outcomes (p
-
7/27/2019 A Review on the Management of Acute Gastroenteritis in Children
7/9
Hong Kong j. emerg. med.Vol. 11(3)Jul 2004158
significant, the clinical effects were modest. Other
beneficial effects included fewer stool,38 better weight
gain,38 and enhancement of intestinal absorption.42
However, there was no signif icant effect on duration
of fever,40,41 number of vomiting38,40,41 body weight
upon discharge39,41 and blood electrolyte.41 Furthermore,
there was no significant adverse effect reported in all
the studies. In view of the modest clinical effects,
dioctahedral smectite is not recommended [IIa, C].
There is no meta-analysis study or RCT on the use
of kaolin-pectin. There was no conclusive evidence
available to show that kaolin-pectin reduce the
duration, stool frequency, or stool fluid losses.7
Use of absorbents may have the disadvantage of
absorbing the nutrients, enzymes and antibiotics in
the intestine.12
Anti -microbial treatment
Most bacterial gastroenteritis do not require or benefit
from antibiotic treatment [Ib, A].6 Antibiotics are
indicated in gastroenteritis caused by Shigella,
Cholera, enteroinvasive E. coli and Clostridium
diff ici le [I I I , C].6,14
Antibiotic therapy is notrecommended for "uncomplicated" Salmonella
enteritis because it does not decrease the duration of
symptoms, diarrhoea, or organism excretion. Besides,
antibiotic therapy has been implicated in prolonging
the carrier state and promoting the emergence of
resistant bacterial strains.20 Therapy for Salmonella
gastroenteritis is reserved for infants younger than
3-6 months of age, in immuno-compromised patients,
and in those who are systemically ill [III, C]. 14
Antibiotics are also indicated in children with sickle
cell disease.2 For Campylobacter gastroenteritis,
erythromycin is indicated for patients with severe or
prolonged illness and to decrease the duration of
shedding.14 For Escherichia coli O157:H 7 infection,
antibiotic treatment may increase the risk of the
haemolytic-uraemic syndrome.43
Management plan and disposal
The indications for hospital admission include:(1) patient with 5% or more dehydration; (2) inability
to manage oral rehydration at home; (3) patient not
tolerating oral rehydration (refusing, vomiting,
insufficient intake); (4) failure of treatment, e.g.,worsening diarrhoea and/or dehydration despite ORT;
(5) other concerns, e.g., diagnosis uncertain, potential
for surgery, child "at risk", child irritable or drowsy,
or child younger than two months [IV, D]. 9 In
addition, parental education should be an essential
element of the management plan. A careful description
of the course of the disorder, firm understanding of
the signs that indicate deterioration, the use of ORT
and method of refeeding should be communicated to
the parents and preferably in a brochure for their
future reference.44
Conclusion
Acute gastroenteritis is a common paediatric illness
seen in emergency departments. Most episodes are self-
limiting. Most of the cases can be attributed to viruses.
Many patients can be managed with oral rehydration
and early reintroduction of feeding. Although most
children with gastroenteritis are successfully managedwith oral rehydration solutions as outpatients, those
high-risk children should be identified and evaluated
carefully. Very young children, children with chronic
diseases, and children with chronic malnutrition
should be managed promptly and in-hospital
treatment may be indicated. As most episodes are self-
limiting, laboratory studies are not usually needed.
Anti-microbial agents should be used judiciously and
only a minority of children will benefit from anti-
microbial therapy. Anti-moti li ty drugs and absorbents
should be discouraged because of limited evidence of
benefit.
References
1. Armon K, Elliott EJ. Acute gastroenteri ti s. In: MoyerVA, Elliott EJ, Davis RL, editors. Evidence basedpediatrics and child health. London: BMJ Books; 2000.p. 273-86.
2. Powell EC, Reynolds SL. Gastroenteri ti s in pediatr ic
emergency medicine: a comprehensive study guide. 2nded. New York: McGraw-Hill; 2002.
-
7/27/2019 A Review on the Management of Acute Gastroenteritis in Children
8/9
Shek et al./Acute gastroenteritis in children 159
3. Nelson EA, Chow E, Lewindon PJ, Biswas R.Management of acute diarrhoea in H ong Kong.J Paediatr Child Health 1997;33(4):360.
4. Gastanaduy AS, Begue RE. Acute gastroenteri tis. Cl inPediatr (Phila) 1999;38(1):1-12.
5. Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinicalguidelines: developing guidelines. BMJ 1999;318(7183):593-6.
6. Mur phy MS. Guideli nes for managing acutegastroenteritis based on a systematic review of publishedresearch. Arch Dis Child 1998;79(3):279-84.
7. Ameri can Academy of Pediatri cs, Provisi onalCommittee on Quali ty Improvement, Subcommit tee onAcute Gastroenteritis. Practice parameter: themanagement of acute gastroenteritis in young children.Pediatrics 1996;97(3):424-35.
8. Gavin N, Merri ck N, Davidson B. Efficacy of glucose-based oral rehydration therapy. Pediatrics 1996;98(1):45-51.
9. Atherl y-John YC, Cunningham SJ, Crain EF. Arandomized trial of oral vs intravenous rehydration ina pediatric emergency department. Arch Pediatr AdolescMed 2002;156(12):1240-3.
10. Sandhu BK ; European Society of Pedi at ri cGastroenterology, Hepatology and Nutrition WorkingGroup on Acute Diarrhoea. Practical guidelines for themanagement of gastroenteritis in children. J PediatrGastroenterol Nutr 2001;33 Suppl 2:S36-9.
11. Armon K, Stephenson T, M acFaul R, Eccleston P,Werneke U. An evidence and consensus based guidelinefor acute diarrhoea management. Arch Dis Child 2001;85(2):132-42.
12. Yeung WKY. Acute gastroenteri t is in infants andchildren. Hong Kong Pract 1999;21:471-6.
13. Fontaine O, Gore SM, Pierce NF. Rice-based oralrehydration solution for treati ng diarrhoea. In: TheCochrane Library. Issue 3, 2000. Oxford: UpdateSoftware [Search date 1998; primary sources: Medline,Embase, Lilacs, Cochrane Controlled Trials Register,and Cochrane Infectious Diseases Group].
14. Kwan EYW, Yeung CY. Fluid and dietary managementof acute infantile diarrhea. Hong Kong J Paediatr (newseries) 2000;5(1):52-60.
15. Isolauri E, Juntunen M, Wiren S, Vuorinen P, KoivulaT. Intestinal permeability changes in acutegastroenteritis: effects of clinical factors and nutritionalmanagement. J Pediatr Gastroenterol Nutr 1989;8(4):466-73.
16. Sandhu BK, I solauri E, Walker-Smith JA, et al. Amulticentre study on behalf of the European Society ofPaediatric Gastroenterology and Nutrition WorkingGroup on Acute Diarrhoea. Early feeding in childhoodgastroenteritis. J Pediatr Gastroenterol Nutr 1997;24(5):522-7.
17. Howie PW, Forsyth JS, Ogston SA, Clark A, FloreyCD. Protective effect of breast feeding against infection.BMJ 1990;300(6716):11-6.
18. Brown KH, Peerson JM, Fontaine O. Use of nonhumanmilks in the dietary management of young children withacute diarrhea: a meta-analysis of clinical trials.Pediatrics 1994;93(1):17-27.
19. Black RE, Lanata CF. Epidemiology of diarrhealdiseases in developing countries. I n: Blaser MJ, SmithPD, Ravdin JI, et al. editors. Infections of thegastrointestinal tract. New York: Raven Press. 1995;58:13-36.
20. Bonadio WA. Acute infectious enterit is in children.Emergency department diagnosis and management.Emerg Med Clin North Am 1995;13(2):457-72.
21. Plevri s JN, Hayes PC. Investigation and managementof acute diarrhoea. Br J Hosp Med 1996;56(11):569-73.
22. Northrup RS, Flanigan TP. Gastroenteri tis. Pediatr Rev1994;15(12):461-72.
23. Karrar ZA, Abdulla MA, Moody JB, Macfarlane SB,Al Bwardy M, Hendrickse RG. Loperamide in acutediarrhoea in childhood: results of a double blind,placebo controlled clinical trial. Ann Trop Paediatr1987;7(2):122-7.
24. Diarrhoeal D iseases Study Group (UK). Loperamidein acute diarrhoea in childhood: results of a doubleblind, placebo controlled mult icentre clinical tr ial. BrMed J (Clin Res Ed) 1984;289(6454):1263-7.
25. Motala C, Hi ll ID , Mann MD, Bowie MD. Effect ofloperamide on stool output and duration of acuteinfectious diarrhea in infants. J Pediatr 1990;117(3):467-71.
26. Kaplan MA, Prior MJ, McKonly KI , DuPont HL,Temple AR, Nelson EB. A multicenter randomizedcontrolled trial of a liquid loperamide product versusplacebo in the treatment of acute diarrhea in children.Clin Pediatr (Phila) 1999;38(10):579-91.
27. Owens JR, Broadhead R, Hendrickse RG, Jaswal OP,Gangal RN. Loperamide in the treatment of acutegastroenteritis in early childhood. Report of a twocentre, double-blind, controlled clinical tr ial. Ann TropPaediatr 1981;1(3):135-41.
28. Bowie MD, H il l I D, M ann MD . Loperamide fortreatment of acute diarrhoea in infants and youngchildren. A double-blind placebo-controlled trial. S AfrMed J 1995;85(9):885-7.
29. Chow CB, Li SH, Leung NK. Loperamide associatednecrotising enterocolitis. Acta Paediatr Scand 1986;75(6):1034-6.
30. Bhutta TI, Tahir KI . Loperamide poisoning in children.Lancet 1990;335(8685):363.
31. Saunders P. Pakistan: misuse of drugs for chi ldhoodillnesses. Lancet 1991;338:438.
32. World Health Organization. The rational use of drugsin the management of acute diarrhoea in children.Geneva: World Health Organization; 1990.
33. Soriano-Brucher H , Avendano P, O 'Ryan M , et al.Bismuth subsalicylate in the treatment of acute diarrheain children: a clinical study. Pediatrics 1991;87(1):18-27.
-
7/27/2019 A Review on the Management of Acute Gastroenteritis in Children
9/9
Hong Kong j. emerg. med.Vol. 11(3)Jul 2004160
34. Figueroa-Quintanilla D, Salazar-Lindo E, Sack RB, et al.A controlled trial of bismuth subsalicylate in infants withacute watery diarrheal disease. N Engl J Med 1993;328(23):1653-8.
35. Chowdhury HR, Yunus M, Zaman K, et al. The efficacyof bismuth subsalicylate in the treatment of acute diarrhoeaand the prevention of persistent diarrhoea. Acta Paediatr2001;90(6):605-10.
36. Welters ID, Menges T, Graf M, Beikirch C, MenzebachA, Hempelmann G. Reduction of postoperative nauseaand vomiting by dimenhydrinate suppositories afterstrabismus surgery in children. Anesth Analg 2000;90(2):311-4.
37. Hardoin RA, Henslee JA, Christenson CP, ChristensonPJ, White M. Colic medication and apparent life-threatening events. Clin Pediatr (Phila) 1991;30(5):281-5.
38. Madkour AA, Madina EM, el-Azzouni OE, Amer MA,el-Walili TM, Abbass T. Smecti te in acute diarrhea inchildren: a double-blind placebo-controlled clinical trial.J Pediatr Gastroenterol Nutr 1993;17(2):176-81.
39. Vivatvakin B, Jongpipatvanich S, Harikul S, Eksaengri P,Lortholary O. Control study of oral rehydration solution(ORS)/ORS + dioctahedral smectite in hospitalized Thaiinfants with acute secretory diarrhea. Southeast Asian JTrop Med Public Health 1992;23(3):414-9.
40. Guarino A, Bisceglia M, Castellucci G, et al. Smectite inthe treatment of acute diarrhea: a nationwide randomizedcontrolled study of the Italian Society of PediatricGast roenterology and H epatology (SI GEP) incollaboration with primary care pediatricians. SIGEPStudy Group for Smectite in Acute Diarrhea. J PediatrGastroenterol Nutr 2001;32(1):71-5.
41. Narkeviciute I, Rudzeviciene O, Leviniene G, MociskieneK, Eidukevicius R. Management of Li thuanian children'sacute diarrhoea with Gastrolit solution and dioctahedralsmectite. Eur J Gastroenterol Hepatol 2002;14(4):419-24.
42. Dupont C, Moreno JL, Barau E, Bargaoui K, Thiane E,Plique O. Effect of diosmectite on intestinal permeabilitychanges in acute diarrhea: a double-blind placebo-controlled trial. J Pediatr Gastroenterol Nutr 1992;14(4):
413-9.43. Wong CS, Jelacic S, H abeeb RL, Watkins SL, Tarr PI.
The risk of the hemolytic-uremic syndrome after antibiotictreatment of Escherichia coli O157:H7 infections. N EnglJ Med 2000;342(26):1930-6.
44. Chiu LH , Li KM, Lok C. Guidelines on management ofgastroenteri tis in young children in A& E departments.A& E Clinical Guidelines, No.13. Hong Kong: HospitalAuthority; 2001 March.